Invio, Inc. (AI) — Funding, Investors & Signals 2026

Invio, Inc.

Ensuring precise data quality in clinical trials, making them faster, easier, and more cost-effective.

Founded 2016 Seed Total: $660.00K AI, Health Care +4

Invio, Inc. is a startup dedicated to ensuring precise data quality in clinical trials, with a slogan that encapsulates its mission: "Ensuring precise data quality in clinical trials, making them faster, easier, and more cost-effective." Founded in 2016, Invio operates at the intersection of AI, Health Care, IT, Information Technology, Life Sciences, and SaaS. The company's cloud-based platform revolutionizes the traditional process of data quality control in clinical trials, aiming to reduce the third of clinical operations costs associated with in-person data review visits to hospitals. Invio's innovative approach involves automatically flagging potential data issues remotely. This technology not only helps verify accurate data recording and the enrollment of appropriate subjects but also allows healthcare professionals to utilize their time more efficiently. The company's last recorded investment was a significant $120.00K Seed Round led by noteworthy investors including Right Side Capital Management, Techstars, and The Cedars-Sinai Accelerator on 15 September 2017. Invio's disruptive solution and strategic investments position it as a promising player in the evolving landscape of clinical trials and data management, offering potential for substantial impact and growth.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round	$120.00K	3	Right Side Capital Management, Techstars +1	15 Sep 2017
Angel Round	Undisclosed	1	Pipeline Angels	25 Apr 2017
Seed Round	$540.00K	1	Seattle Angel Conference	16 Nov 2016

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round

$120.00K

Right Side Capital Management, Techstars +1

15 Sep 2017

Angel Round

Undisclosed

Pipeline Angels

25 Apr 2017

Seed Round

$540.00K

Seattle Angel Conference

16 Nov 2016

FAQ About Invio, Inc.

Ensuring precise data quality in clinical trials, making them faster, easier, and more cost-effective.

Invio, Inc. was founded in 2016.

Invio, Inc. operates in AI, Health Care, IT, Information Technology, Life Sciences and SaaS. Its work centres on clinical trials, data quality control, FDA compliance and cloud-based platform.

Invio, Inc. has completed 3 funding rounds, raising a total of $660.00K. The latest funding stage is Seed.

Top alternatives and competitors to Invio, Inc. include Vios Medical, BioT, Carematix Inc., CluePoints, HuCare. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Invio, Inc. and Vios Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Invio, Inc.

General Information

Discover More

About Invio, Inc.

Funding Rounds & Investors (3)

Invio, Inc. Alternatives & Competitors

FAQ About Invio, Inc.